English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 13, 2026

Solent student secures roles in trauma simulation for NHS and British military
+ Pharmaceuticals
Patient Daily | Jun 13, 2026

Researchers recommend new DNA test for rare genetic disorder diagnosis
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

Written exposure therapy offers scalable approach for PTSD treatment, report says
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

Study finds trauma-related conditions drive deaths in women with HIV
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

Investors see growing biotech opportunities in Spain and Portugal amid maturing capital networks
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

Parkinson's drug pramipexole shows promise for anhedonia in treatment-resistant depression
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

Researchers identify cerebellar mechanism influencing social behavior in autism spectrum disorder
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

University of Oklahoma receives $11.5 million NIH grant for immunoengineering center

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation